10-Q Filing

UNITEDHEALTH GROUP INC CIK: 731766 Q1 2022

Filing Information

Form Type	10-Q
Accession Number	`0000731766-22-000019`
Period End Date	20220331
Filing Date	20220504
Fiscal Year	2022
Fiscal Period	Q1
XBRL Instance	unh-20220331_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 84 Income Statement 42 Cash Flow Statement 64 Stockholders Equity 34 Comprehensive Income 24

Balance Sheet 84 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$25.48B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$21.38B	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Short-term investments	`ShortTermInvestments`	$2.53B	USD	Point-in-time
Short-term investments	`ShortTermInvestments`	$2.91B	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$18.87B	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$14.22B	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	3.00B	shares	Point-in-time
Other current receivables, net	`OtherReceivablesNetCurrent`	$13.87B	USD	Point-in-time
Other current receivables, net	`OtherReceivablesNetCurrent`	$11.99B	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	3.00B	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	941.00M	shares	Point-in-time
Assets under management	`AarpAssetsUnderManagement`	$4.16B	USD	Point-in-time
Assets under management	`AarpAssetsUnderManagement`	$4.45B	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	939.00M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$5.61B	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$5.32B	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	941.00M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	939.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$61.76B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$69.03B	USD	Point-in-time
Long-term investments	`LongTermInvestments`	$42.35B	USD	Point-in-time
Long-term investments	`LongTermInvestments`	$43.11B	USD	Point-in-time
Property, equipment and capitalized software, net	`PropertyPlantAndEquipmentNet`	$8.97B	USD	Point-in-time
Property, equipment and capitalized software, net	`PropertyPlantAndEquipmentNet`	$9.18B	USD	Point-in-time
Goodwill	`Goodwill`	$75.80B	USD	Point-in-time
Goodwill	`Goodwill`	$77.55B	USD	Point-in-time
Other intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$10.04B	USD	Point-in-time
Other intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$9.92B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$12.53B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$13.21B	USD	Point-in-time
Total assets	`Assets`	$212.21B	USD	Point-in-time
Total assets	`Assets`	$221.24B	USD	Point-in-time
Medical costs payable	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$24.83B	USD	Point-in-time
Medical costs payable	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$24.48B	USD	Point-in-time
Medical costs payable	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$21.87B	USD	Point-in-time
Medical costs payable	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$28.68B	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$25.06B	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$24.64B	USD	Point-in-time
Short-term borrowings and current maturities of long-term debt	`DebtCurrent`	$6.70B	USD	Point-in-time
Short-term borrowings and current maturities of long-term debt	`DebtCurrent`	$3.62B	USD	Point-in-time
Unearned revenues	`DeferredRevenueCurrent`	$2.57B	USD	Point-in-time
Unearned revenues	`DeferredRevenueCurrent`	$2.67B	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$25.06B	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$22.98B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$88.17B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$78.29B	USD	Point-in-time
Long-term debt, less current maturities	`LongTermDebtNoncurrent`	$42.38B	USD	Point-in-time
Long-term debt, less current maturities	`LongTermDebtNoncurrent`	$40.80B	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$3.27B	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$2.95B	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$11.79B	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$11.67B	USD	Point-in-time
Total liabilities	`Liabilities`	$135.73B	USD	Point-in-time
Total liabilities	`Liabilities`	$143.59B	USD	Point-in-time
Commitments and contingencies (Note 5)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 5)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Redeemable noncontrolling interests	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$1.43B	USD	Point-in-time
Redeemable noncontrolling interests	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$1.52B	USD	Point-in-time
Preferred stock, $0.001 par value - 10 shares authorized; no shares issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value - 10 shares authorized; no shares issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.01 par value - 3,000 shares authorized; 939 and 941 issued and outstanding	`CommonStockValue`	$10.00M	USD	Point-in-time
Common stock, $0.01 par value - 3,000 shares authorized; 939 and 941 issued and outstanding	`CommonStockValue`	$10.00M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$78.78B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$77.13B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-5.38B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-6.03B	USD	Point-in-time
Nonredeemable noncontrolling interests	`MinorityInterest`	$3.36B	USD	Point-in-time
Nonredeemable noncontrolling interests	`MinorityInterest`	$3.29B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$75.05B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$69.31B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$76.13B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$68.33B	USD	Point-in-time
Total liabilities, redeemable noncontrolling interests and equity	`LiabilitiesAndStockholdersEquity`	$221.24B	USD	Point-in-time
Total liabilities, redeemable noncontrolling interests and equity	`LiabilitiesAndStockholdersEquity`	$212.21B	USD	Point-in-time

Income Statement 42 line items

Line Item	Tag	Value	Unit	Period
Premiums	`PremiumsEarnedNet`	$64.07B	USD	1 Quarter
Premiums	`PremiumsEarnedNet`	$55.49B	USD	1 Quarter
Investment and other income	`InvestmentIncomeInterestAndDividend`	$452.00M	USD	1 Quarter
Investment and other income	`InvestmentIncomeInterestAndDividend`	$367.00M	USD	1 Quarter
Total revenues	`Revenues`	$80.15B	USD	1 Quarter
Total revenues	`Revenues`	$70.20B	USD	1 Quarter
Medical costs	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$52.52B	USD	1 Quarter
Medical costs	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$44.90B	USD	1 Quarter
Operating costs	`SellingGeneralAndAdministrativeExpense`	$11.40B	USD	1 Quarter
Operating costs	`SellingGeneralAndAdministrativeExpense`	$10.22B	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$7.57B	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$8.49B	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$788.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$758.00M	USD	1 Quarter
Total operating costs	`CostsAndExpenses`	$73.20B	USD	1 Quarter
Total operating costs	`CostsAndExpenses`	$63.46B	USD	1 Quarter
Earnings from operations	`OperatingIncomeLoss`	$6.74B	USD	1 Quarter
Earnings from operations	`OperatingIncomeLoss`	$6.95B	USD	1 Quarter
Interest expense	`InterestExpense`	$397.00M	USD	1 Quarter
Interest expense	`InterestExpense`	$433.00M	USD	1 Quarter
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$6.34B	USD	1 Quarter
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$6.52B	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$1.37B	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$1.36B	USD	1 Quarter
Net earnings	`ProfitLoss`	$4.98B	USD	1 Quarter
Net earnings	`ProfitLoss`	$5.15B	USD	1 Quarter
Earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$121.00M	USD	1 Quarter
Earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$116.00M	USD	1 Quarter
Net earnings attributable to UnitedHealth Group common shareholders	`NetIncomeLoss`	$4.86B	USD	1 Quarter
Net earnings attributable to UnitedHealth Group common shareholders	`NetIncomeLoss`	$5.03B	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$5.34	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$5.14	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$5.08	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$5.27	USD	1 Quarter
Basic weighted-average number of common shares outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	941.00M	shares	1 Quarter
Basic weighted-average number of common shares outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	945.00M	shares	1 Quarter
Dilutive effect of common share equivalents	`WeightedAverageNumberDilutedSharesOutstandingAdjustment`	12.00M	shares	1 Quarter
Dilutive effect of common share equivalents	`WeightedAverageNumberDilutedSharesOutstandingAdjustment`	13.00M	shares	1 Quarter
Diluted weighted-average number of common shares outstanding	`WeightedAverageNumberOfDilutedSharesOutstanding`	957.00M	shares	1 Quarter
Diluted weighted-average number of common shares outstanding	`WeightedAverageNumberOfDilutedSharesOutstanding`	954.00M	shares	1 Quarter
Anti-dilutive shares excluded from the calculation of dilutive effect of common share equivalents	`AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount`	2.00M	shares	1 Quarter
Anti-dilutive shares excluded from the calculation of dilutive effect of common share equivalents	`AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount`	3.00M	shares	1 Quarter

Cash Flow Statement 64 line items

Line Item	Tag	Value	Unit	Period
Net earnings	`ProfitLoss`	$4.98B	USD	1 Quarter
Net earnings	`ProfitLoss`	$5.15B	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$788.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$758.00M	USD	1 Quarter
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$161.00M	USD	1 Quarter
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$341.00M	USD	1 Quarter
Share-based compensation	`ShareBasedCompensation`	$299.00M	USD	1 Quarter
Share-based compensation	`ShareBasedCompensation`	$256.00M	USD	1 Quarter
Other, net	`OtherNoncashIncomeExpense`	$55.00M	USD	1 Quarter
Other, net	`OtherNoncashIncomeExpense`	$-17.00M	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$4.52B	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$2.90B	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$955.00M	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$1.09B	USD	1 Quarter
Medical costs payable	`IncreaseDecreaseInHealthCareInsuranceLiabilities`	$2.97B	USD	1 Quarter
Medical costs payable	`IncreaseDecreaseInHealthCareInsuranceLiabilities`	$3.85B	USD	1 Quarter
Accounts payable and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$870.00M	USD	1 Quarter
Accounts payable and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$589.00M	USD	1 Quarter
Unearned revenues	`IncreaseDecreaseInDeferredRevenue`	$78.00M	USD	1 Quarter
Unearned revenues	`IncreaseDecreaseInDeferredRevenue`	$-261.00M	USD	1 Quarter
Cash flows from operating activities	`NetCashProvidedByUsedInOperatingActivities`	$6.00B	USD	1 Quarter
Cash flows from operating activities	`NetCashProvidedByUsedInOperatingActivities`	$5.32B	USD	1 Quarter
Purchases of investments	`PaymentsToAcquireInvestments`	$4.61B	USD	1 Quarter
Purchases of investments	`PaymentsToAcquireInvestments`	$4.98B	USD	1 Quarter
Sales of investments	`ProceedsFromSaleOfAvailableForSaleSecuritiesDebt`	$1.59B	USD	1 Quarter
Sales of investments	`ProceedsFromSaleOfAvailableForSaleSecuritiesDebt`	$643.00M	USD	1 Quarter
Maturities of investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$1.76B	USD	1 Quarter
Maturities of investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$2.25B	USD	1 Quarter
Cash paid for acquisitions, net of cash assumed	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$1.19B	USD	1 Quarter
Cash paid for acquisitions, net of cash assumed	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$1.23B	USD	1 Quarter
Purchases of property, equipment and capitalized software	`PaymentsToAcquirePropertyPlantAndEquipment`	$568.00M	USD	1 Quarter
Purchases of property, equipment and capitalized software	`PaymentsToAcquirePropertyPlantAndEquipment`	$555.00M	USD	1 Quarter
Other, net	`PaymentsForProceedsFromOtherInvestingActivities`	$255.00M	USD	1 Quarter
Other, net	`PaymentsForProceedsFromOtherInvestingActivities`	$232.00M	USD	1 Quarter
Cash flows used for investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-3.71B	USD	1 Quarter
Cash flows used for investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-3.67B	USD	1 Quarter
Common share repurchases	`PaymentsForRepurchaseOfCommonStock`	$2.50B	USD	1 Quarter
Common share repurchases	`PaymentsForRepurchaseOfCommonStock`	$1.65B	USD	1 Quarter
Cash dividends paid	`PaymentsOfDividendsCommonStock`	$1.36B	USD	1 Quarter
Cash dividends paid	`PaymentsOfDividendsCommonStock`	$1.18B	USD	1 Quarter
Proceeds from common stock issuances	`ProceedsFromIssuanceOfCommonStock`	$551.00M	USD	1 Quarter
Proceeds from common stock issuances	`ProceedsFromIssuanceOfCommonStock`	$436.00M	USD	1 Quarter
Repayments of long-term debt	`RepaymentsOfLongTermDebt`	$1.10B	USD	1 Quarter
Repayments of long-term debt	`RepaymentsOfLongTermDebt`	$1.15B	USD	1 Quarter
Proceeds from short-term borrowings, net	`ProceedsFromRepaymentsOfCommercialPaper`	$4.06B	USD	1 Quarter
Proceeds from short-term borrowings, net	`ProceedsFromRepaymentsOfCommercialPaper`	$3.15B	USD	1 Quarter
Customer funds administered	`IncreaseDecreaseInDeposits`	$5.12B	USD	1 Quarter
Customer funds administered	`IncreaseDecreaseInDeposits`	$2.13B	USD	1 Quarter
Other, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$-1.55B	USD	1 Quarter
Other, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$-1.86B	USD	1 Quarter
Cash flows from financing activities	`NetCashProvidedByUsedInFinancingActivities`	$2.30B	USD	1 Quarter
Cash flows from financing activities	`NetCashProvidedByUsedInFinancingActivities`	$787.00M	USD	1 Quarter
Effect of exchange rate on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-51.00M	USD	1 Quarter
Effect of exchange rate on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$157.00M	USD	1 Quarter
Increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$3.03B	USD	1 Quarter
Increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$4.11B	USD	1 Quarter
Cash, and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$25.48B	USD	Point-in-time
Cash, and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$16.92B	USD	Point-in-time
Cash, and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$21.38B	USD	Point-in-time
Cash, and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$19.95B	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$25.48B	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$16.92B	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$21.38B	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$19.95B	USD	Point-in-time

Stockholders Equity 34 line items

Line Item	Tag	Value	Unit	Period
Cash dividends per common share	`CommonStockDividendsPerShareCashPaid`	$1.25	USD	1 Quarter
Cash dividends per common share	`CommonStockDividendsPerShareCashPaid`	$1.45	USD	1 Quarter
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$75.05B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$69.31B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$76.13B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$68.33B	USD	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	941.00M	shares	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	939.00M	shares	Point-in-time
Net earnings attributable to UnitedHealth Group common shareholders	`NetIncomeLoss`	$4.86B	USD	1 Quarter
Net earnings attributable to UnitedHealth Group common shareholders	`NetIncomeLoss`	$5.03B	USD	1 Quarter
Net Earnings, Including Portion Attributable to Nonredeemable Noncontrolling Interest	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$4.94B	USD	1 Quarter
Net Earnings, Including Portion Attributable to Nonredeemable Noncontrolling Interest	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$5.12B	USD	1 Quarter
Other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$-1.01B	USD	1 Quarter
Other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$-642.00M	USD	1 Quarter
Issuances of common stock, and related tax effects	`StockIssuedDuringPeriodValueNewIssues`	$333.00M	USD	1 Quarter
Issuances of common stock, and related tax effects	`StockIssuedDuringPeriodValueNewIssues`	$256.00M	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$282.00M	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$242.00M	USD	1 Quarter
Common share repurchases	`StockRepurchasedAndRetiredDuringPeriodValue`	$1.65B	USD	1 Quarter
Common share repurchases	`StockRepurchasedAndRetiredDuringPeriodValue`	$2.50B	USD	1 Quarter
Cash dividends paid on common shares ($1.45 per share and $1.25 per share for the three months ended March 31, 2022, and 2021, respectively)	`DividendsCash`	$1.18B	USD	1 Quarter
Cash dividends paid on common shares ($1.45 per share and $1.25 per share for the three months ended March 31, 2022, and 2021, respectively)	`DividendsCash`	$1.36B	USD	1 Quarter
Redeemable noncontrolling interests fair value and other adjustments	`MinorityInterestChangeInRedemptionValue`	$-131.00M	USD	1 Quarter
Redeemable noncontrolling interests fair value and other adjustments	`MinorityInterestChangeInRedemptionValue`	$-604.00M	USD	1 Quarter
Acquisition and other adjustments of nonredeemable noncontrolling interests	`MinorityInterestPeriodIncreaseDecrease`	$66.00M	USD	1 Quarter
Acquisition and other adjustments of nonredeemable noncontrolling interests	`MinorityInterestPeriodIncreaseDecrease`	$91.00M	USD	1 Quarter
Distribution to nonredeemable noncontrolling interests	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$74.00M	USD	1 Quarter
Distribution to nonredeemable noncontrolling interests	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$102.00M	USD	1 Quarter
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$75.05B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$69.31B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$76.13B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$68.33B	USD	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	941.00M	shares	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	939.00M	shares	Point-in-time

Comprehensive Income 24 line items

Line Item	Tag	Value	Unit	Period
Net earnings	`ProfitLoss`	$4.98B	USD	1 Quarter
Net earnings	`ProfitLoss`	$5.15B	USD	1 Quarter
Gross unrealized losses on investment securities during the period	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$-2.02B	USD	1 Quarter
Gross unrealized losses on investment securities during the period	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$-764.00M	USD	1 Quarter
Income tax effect	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	$-174.00M	USD	1 Quarter
Income tax effect	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	$-465.00M	USD	1 Quarter
Total unrealized losses, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-1.56B	USD	1 Quarter
Total unrealized losses, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-590.00M	USD	1 Quarter
Gross reclassification adjustment for net realized gains included in net earnings	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax`	$3.00M	USD	1 Quarter
Gross reclassification adjustment for net realized gains included in net earnings	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax`	$7.00M	USD	1 Quarter
Income tax effect	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax`	$1.00M	USD	1 Quarter
Income tax effect	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax`	$2.00M	USD	1 Quarter
Total reclassification adjustment, net of tax	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax`	$2.00M	USD	1 Quarter
Total reclassification adjustment, net of tax	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax`	$5.00M	USD	1 Quarter
Total foreign currency translation gains (losses)	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-417.00M	USD	1 Quarter
Total foreign currency translation gains (losses)	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$918.00M	USD	1 Quarter
Other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$-1.01B	USD	1 Quarter
Other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$-642.00M	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$4.51B	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$3.97B	USD	1 Quarter
Comprehensive income attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$116.00M	USD	1 Quarter
Comprehensive income attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$121.00M	USD	1 Quarter
Comprehensive income attributable to UnitedHealth Group common shareholders	`ComprehensiveIncomeNetOfTax`	$3.85B	USD	1 Quarter
Comprehensive income attributable to UnitedHealth Group common shareholders	`ComprehensiveIncomeNetOfTax`	$4.38B	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.